Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00248729 · ClinicalTrials.gov registry record · Phase 2
Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital.
A Phase 2 study, sponsored by St. Luke's Hospital, Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00248729: Completed Phase 2 study, sponsored by St. Luke's Hospital, Pennsylvania.
NCT00248729 is a Phase 2 study that has completed, run by St. Luke's Hospital, Pennsylvania. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00248729, a Phase 2 study, has completed, sponsored by St. Luke's Hospital, Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance.
Interventions
- DRUG Etomidate (20mg) or Midazolam (7mg)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-10 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
What the finished NCT00248729 record still lists
NCT00248729 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Etomidate (20mg) or Midazolam (7mg) is the first listed.
NCT00248729 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00248729 about?
NCT00248729 is a clinical study titled "Effectiveness and Safety Study of Etomidate Versus Midazolam to Help Place a Breathing Tube Outside of the Hospital.". The objective of this study was to compare the utility of etomidate and midazolam in helping patients to relax when there was a need for the placement of a ventilation tube by medics who were transporting patients to a hospital in an ambulance.
What is the current status of trial NCT00248729?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-10. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00248729?
The interventions under investigation include: Etomidate (20mg) or Midazolam (7mg) (DRUG).
Who is sponsoring clinical trial NCT00248729?
This trial is sponsored by St. Luke's Hospital, Pennsylvania, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia